Home » Topics » Regulatory » Patents

Patents
RSS

Dual NEP/ACE inhibitors claimed by Eisai

Dec. 20, 1996

Antineoplastic anthracycline antibiotic disclosed by Mercian

Dec. 19, 1996

Mercian reports new antitumor anthracycline

Dec. 19, 1996

Radiopharmaceutical agents from CIS Bio International

Dec. 19, 1996

New lipophilic drug delivery agents from Scotia

Dec. 19, 1996

Bayer describes new ASA derivatives

Dec. 19, 1996

Therapeutically active nicotinic acid esters described by Scotia

Dec. 19, 1996

Carbapenem esters revealed by SKB

Dec. 18, 1996

Mercian discloses novel antitumor anthracycline antibiotics

Dec. 18, 1996

Sandoz reports on tetraline derivatives for neurological disorders

Dec. 18, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...